Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Apr 02, 2024 11:44am
43 Views
Post# 35965260

RE:RE:RE:RE:RE:RE:Insider trading.

RE:RE:RE:RE:RE:RE:Insider trading.
mdjbrown wrote: As alley said okgonow, insiders have arrangements to protect them if selling shares during a "material event" or cooling off period.

The execs at Medipharm are far to experienced to risk regulatory sanctions for insider trading on material news not made public.

"A complete 10b5-1 plan will include the number or dollar value of shares to be sold, the sale date, and for a limit order, the dates the order will remain open. Once in place, the executive, or any other person who may have material nonpublic information, may not change the parameters of the plan."

"Companies that facilitate the sale of shares to cover tax withholdings due in connection with the vesting of restricted stock or restricted stock units (a “sell-to-cover”) would need to ensure that the required cooling-off period has been met between the award holder's entry into the Rule 10b5-1 sell-to-cover .."

 


The 10b5-1 rule is a US rule not Canadian

if you could post equivilant Canadian rule that would be great

or if the sales were made on US exchanges please post that 

I think all shares received by MPL board are received as Canadian equities as the company is a registered Canadian company
<< Previous
Bullboard Posts
Next >>